case_images: PMC10645462_01
case_images: Fundus photographs and OCT of both eyes before IVBr. a Fundus photograph of the right eye shows macula atrophy and subretinal hard exudate at the inferior retina due to subretinal hemorrhage. b Fundus photograph of the left eye shows macula atrophy and slight subretinal hemorrhage. c OCT of the right eye shows type 2 nAMD. d OCT of the left eye shows type 2 nAMD and slight intraretinal fluid. IVBr, intravitreal brolucizumab injection; OCT, optical coherence tomography; nAMD, neovascular age-related macular degeneration.
case_images: cop-2023-0014-0001-534817_F01.jpg
case_images: PMC10645462_01_cop-2023-0014-0001-534817_F01.jpg
case_images: F1
case_images: The fundus photographs and optical coherence tomography findings are shown in Figure 1.
case_images: Fundus photograph and OCT of the right eye at the onset of IOI caused by IVBr. a Fundus photograph shows retinal vasculitis at the inferior retina (arrowheads). b OCT is blurry and shows choroid thickening. OCT, optical coherence tomography; IOI, intraocular inflammation; IVBr, intravitreal brolucizumab injection.
case_images: cop-2023-0014-0001-534817_F02.jpg
case_images: PMC10645462_01_cop-2023-0014-0001-534817_F02.jpg
case_images: F2
case_images: Fundus photographs and optical coherence tomography findings are shown in Figure 2.
case_images: OCT of the right eye before IVBr, at the onset of IOI, and 225 days after injection. a OCT before IVBr. CCT was 240 mum (arrowheads). b OCT at the onset of IOI. CCT was 436 mum. c OCT 225 days after IVBr. CCT was 84 mum. OCT, optical coherence tomography; IOI, intraocular inflammation; IVBr, intravitreal brolucizumab injection; CCT, central choroidal thickness.
case_images: cop-2023-0014-0001-534817_F03.jpg
case_images: PMC10645462_01_cop-2023-0014-0001-534817_F03.jpg
case_images: F3
case_images: The progression of CCT is shown in Figure 3.